drugset / Trial / NCT05549804
A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a single center, open-label, dose increasing study to evaluate the safety, tolerability, pharmacokinetic(PK) profile, and antitumor efficacy of KL340399 intratumoral in patients with advanced solid tumors.
Timeline
- Start
- 2022-08-30
- Primary completion
- 2025-04-21
- Completion
- 2025-04-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KL340399 | Unknown | — | Other |